Resmed (RSMDF) Finished Goods (2010 - 2026)

Resmed has reported Finished Goods for 17 years, with the latest figure at $559.0 million in Q1 2026.

• For the quarter ending Q1 2026, Finished Goods rose 8.25% year-over-year to $559.0 million; the trailing twelve-month figure through Mar 2026 stood at $559.0 million (up 8.25% YoY), and the FY2025 full-year result was $557.9 million, up 20.24% from the prior year.
• Finished Goods for Q1 2026 stood at $559.0 million, up from $546.3 million in the prior quarter.
• The five-year high for Finished Goods was $580.5 million in Q3 2025, with the low at $320.1 million in Q1 2022.
• Historically, Finished Goods has averaged $497.3 million across 5 years, with a median of $522.5 million in 2022.
• Annual changes were most pronounced in 2022 — Finished Goods soared 96.76% — and 2024, when it declined 21.89%.
• Resmed's Finished Goods stood at $522.5 million in 2022, then declined by 11.38% to $463.0 million in 2023, then grew by 11.16% to $514.7 million in 2024, then grew by 6.14% to $546.3 million in 2025, then increased by 2.31% to $559.0 million in 2026.
• The last three Finished Goods figures came in at $559.0 million (Q1 2026), $546.3 million (Q4 2025), and $580.5 million (Q3 2025), per Business Quant data.